Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could ...

The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.

(Family Features) Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...